An EU perspective on the use of in vitro methods in regulatory pharmaceutical toxicology

Toxicology Letters

Volumn 127, Issue 1-3, 2002, Pages 161-168

  Snodin, David J ^a  

^a MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

Author keywords

Alternative methods; Drug toxicology; Regulatory toxicology

Indexed keywords

CYTOCHROME P450; RECEPTOR;

BIOLOGICAL MODEL; CELL CULTURE; CONFERENCE PAPER; DRUG RESEARCH; DRUG SAFETY; EUROPE; GENOMICS; GENOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; MEDICAL LITERATURE; METABOLIC ACTIVATION; METABOLISM; METABOLITE; METHODOLOGY; MICROSOME; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEOMICS; RECEPTOR BINDING; REGULATORY MECHANISM; REGULATORY PHARMACEUTICAL TOXICOLOGY; TOXICOGENOMICS; TOXICOLOGY; TOXICOPROTEOMICS; TRANSGENICS; VALIDATION PROCESS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DRUG INDUSTRY; EUROPEAN UNION; HUMANS; LEGISLATION, DRUG; PHARMACEUTICAL PREPARATIONS; PHARMACOGENETICS; PHARMACOLOGY; RISK ASSESSMENT; TOXICOLOGY;

ANIMALIA;

EID: 0037186874     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(01)00496-9     Document Type: Conference Paper

References (20)

1. Application of complementary DNA microarray technology to carcinogen identification, toxicology and drug safety evaluation
2. Induction of chromosome aberrations in vitro by phenolphthalein: Mechanistic studies
3. The integrated use of alternative methods in toxicological risk evaluation
4. An integrated approach to the prediction of systemic toxicity using computer-based biokinetic models and biological in vitro test methods: A prevalidation study based on the ECITTS project
5. The national toxicology program evaluation of genetically altered mice as predictive models for identifying carcinogens
6. Microarrays and toxicology: The advent of toxicogenomics
7. Genomics: Implications for toxicology
8. Concordance of the toxicity of pharmaceuticals in humans and in animals
9. Protein chips-delivering on the promise of genomics
10. DNA arrays: Technology, options and toxicological applications
11. Chromosome maps of man and mouse. IV
12. Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models
13. Harmonisation of international toxicity testing guidelines for pharmaceuticals. Contributions to refinement and reduction in animal use
14. Transgenic and gene knockout mice in cancer research
15. The impact of genomics-based technologies on drug safety evaluation